Recent patent reform bills and their implications for prescription drugs

JAMA

13 January 2022 - In 2022, several bills were introduced in Congress to revamp US intellectual property law. 

Although these bills did not receive a full vote in the turmoil of the previous election year, they show momentum gathering among legislators to introduce intellectual property reforms in the name of promoting innovation.

Read JAMA Viewpoint

Michael Wonder

Posted by:

Michael Wonder